CHICAGO, Illinois, May 25, 2016 – KMR Group, a leader in biopharmaceutical R&D performance analytics, announces a significant milestone in their clinical performance dataset: reaching over 25,000 clinical trials and encompassing over 400,000 sites. The company’s expanding client base and product offerings prompted the increase.
As clinical trial complexity increases and geographic scope is broadened, biopharmaceutical companies and CROs increasingly need access to performance information beyond their own past performance. The need for vetted clinical trial performance data has also grown as these companies strive to conduct more efficient clinical trials. Utilizing Industry performance helps the companies evaluate clinical trial performance and aid in trial, enrollment and site planning.
KMR Group’s clinical dataset provides Industry data at the trial level, site level and individual site level. All companies accessing the Industry dataset must submit their own trial and site performance details in order to compare their performance as well as have access to Industry results. The data is used in reports, benchmarking studies as well as online applications. With clinical applications ranging from the trial performance planning tool Cycle Time Metrix Application to the individual site performance and ranking Site Scorecard Application, using precision analytics for planning and evaluating trial and site performance has never been easier.
KMR Group attributes the quality and depth of performance information as a key differentiator of their company enabling more sophisticated analysis and precision analytics since unlike many providers using public data, the KMR Group data is proprietary. “Any company looking to use data for purposes of performance evaluation and decision making wants to be confident in the source of that information, since it can have tremendous implications on cost and time. This impressive milestone is reflective of the confidence placed in KMR Group by our clients,” commented Linda Martin, KMR Group President and Founder.
Current clients subscribed to KMR Group’s CORE Enrollment or Cycle Time Metrix applications have immediate access to the larger Industry dataset. Companies interested in licensing the applications are encouraged to contact KMR Group.
For more information about KMR’s clinical applications contact:
Lyndsey McKay, Marketing and Communications Manager
Tel: +1 (312) 795-0400
Email: lmckay [at] kmrgroup.com
About KMR
KMR Group has worked exclusively in biopharmaceutical R&D since the early 1990s. KMR Group is an industry leader in benchmarking, analytics and performance management as well as a developer of on-line analytics tools that enable access to our propriety and rich datasets. KMR's clinical platform contains the most reliable source for trial performance, recruitment and site metrics data, with over 25,000 global clinical trials. Clients depend on these tools to benchmark performance, define recruitment strategies and shape enrollment plans and to identify best performing sites. For more information or for a demonstration of any of KMR's tools, please contact us.
As clinical trial complexity increases and geographic scope is broadened, biopharmaceutical companies and CROs increasingly need access to performance information beyond their own past performance. The need for vetted clinical trial performance data has also grown as these companies strive to conduct more efficient clinical trials. Utilizing Industry performance helps the companies evaluate clinical trial performance and aid in trial, enrollment and site planning.
KMR Group’s clinical dataset provides Industry data at the trial level, site level and individual site level. All companies accessing the Industry dataset must submit their own trial and site performance details in order to compare their performance as well as have access to Industry results. The data is used in reports, benchmarking studies as well as online applications. With clinical applications ranging from the trial performance planning tool Cycle Time Metrix Application to the individual site performance and ranking Site Scorecard Application, using precision analytics for planning and evaluating trial and site performance has never been easier.
KMR Group attributes the quality and depth of performance information as a key differentiator of their company enabling more sophisticated analysis and precision analytics since unlike many providers using public data, the KMR Group data is proprietary. “Any company looking to use data for purposes of performance evaluation and decision making wants to be confident in the source of that information, since it can have tremendous implications on cost and time. This impressive milestone is reflective of the confidence placed in KMR Group by our clients,” commented Linda Martin, KMR Group President and Founder.
Current clients subscribed to KMR Group’s CORE Enrollment or Cycle Time Metrix applications have immediate access to the larger Industry dataset. Companies interested in licensing the applications are encouraged to contact KMR Group.
For more information about KMR’s clinical applications contact:
Lyndsey McKay, Marketing and Communications Manager
Tel: +1 (312) 795-0400
Email: lmckay [at] kmrgroup.com
About KMR
KMR Group has worked exclusively in biopharmaceutical R&D since the early 1990s. KMR Group is an industry leader in benchmarking, analytics and performance management as well as a developer of on-line analytics tools that enable access to our propriety and rich datasets. KMR's clinical platform contains the most reliable source for trial performance, recruitment and site metrics data, with over 25,000 global clinical trials. Clients depend on these tools to benchmark performance, define recruitment strategies and shape enrollment plans and to identify best performing sites. For more information or for a demonstration of any of KMR's tools, please contact us.
